Squarepoint’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.8M Buy
267,703
+106,972
+67% +$5.76M 0.03% 862
2025
Q4
$7.79M Buy
160,731
+92,717
+136% +$3.61M 0.02% 1202
2025
Q3
$2.08M Sell
68,014
-41,374
-38% -$950K ﹤0.01% 2069
2025
Q2
$2.43M Buy
+109,388
New +$2.29M 0.01% 1955
2025
Q1
Sell
-80,870
Closed -$1.07M 4522
2024
Q4
$1.07M Buy
80,870
+36,365
+82% +$881K ﹤0.01% 3007
2024
Q3
$1.49M Buy
44,505
+33,320
+298% +$1.14M ﹤0.01% 2293
2024
Q2
$280K Sell
11,185
-482
-4% -$11.2K ﹤0.01% 3470
2024
Q1
$263K Sell
11,667
-6,256
-35% -$148K ﹤0.01% 3471
2023
Q4
$384K Sell
17,923
-34,530
-66% -$596K ﹤0.01% 3197
2023
Q3
$942K Buy
52,453
+20,968
+67% +$400K ﹤0.01% 2362
2023
Q2
$640K Buy
31,485
+1,383
+5% +$28K ﹤0.01% 2472
2023
Q1
$655K Buy
30,102
+13,319
+79% +$324K ﹤0.01% 2148
2022
Q4
$520K Sell
16,783
-21,926
-57% -$619K ﹤0.01% 2265
2022
Q3
$987K Sell
38,709
-9,202
-19% -$216K 0.01% 1781
2022
Q2
$973K Buy
+47,911
New +$1.06M 0.01% 1626
2020
Q4
Sell
-20,473
Closed -$302K 2883
2020
Q3
$302K Buy
+20,473
New +$369K ﹤0.01% 1794
2020
Q2
Sell
-13,086
Closed -$185K 2205
2020
Q1
$185K Sell
13,086
-2,307
-15% -$35K ﹤0.01% 1502
2019
Q4
$250K Buy
15,393
+3,608
+31% +$85.3K ﹤0.01% 2123
2019
Q3
$412K Buy
11,785
+2,475
+27% +$118K ﹤0.01% 1719
2019
Q2
$525K Sell
9,310
-8,290
-47% -$597K 0.01% 1635
2019
Q1
$1.29M Buy
17,600
+7,736
+78% +$534K 0.01% 969
2018
Q4
$629K Sell
9,864
-8,190
-45% -$609K 0.01% 1137
2018
Q3
$1.8M Buy
18,054
+3,454
+24% +$287K 0.02% 764
2018
Q2
$1.04M Buy
14,600
+12,300
+535% +$1.03M 0.01% 879
2018
Q1
$239K Sell
2,300
-6,313
-73% -$712K ﹤0.01% 1419
2017
Q4
$868K Buy
+8,613
New +$634K 0.02% 892

Other funds holding ANAB